Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Zhongguo Zhong Yao Za Zhi ; 48(9): 2273-2283, 2023 May.
Artigo em Chinês | MEDLINE | ID: mdl-37282856

RESUMO

The active ingredients in traditional Chinese medicine(TCM)are the foundation for the efficiency of TCM and the key to the formation of Dao-di herbs. It is of great significance to study the biosynthesis and regulation mechanisms of these active ingredients for analyzing the formation mechanism of Daodi herbs and providing components for the production of active ingredients in TCM by synthetic biology. With the advancements in omics technology, molecular biology, synthetic biology, artificial intelligence, etc., the analysis of biosynthetic pathways for active ingredients in TCM is rapidly progressing. New methods and technologies have promoted the analysis of the synthetic pathways of active ingredients in TCM and have also made this area a hot topic in molecular pharmacognosy. Many researchers have made significant progress in analyzing the biosynthetic pathways of active ingredients in TCM such as Panax ginseng, Salvia miltiorrhiza, Glycyrrhiza uralensis, and Tripterygium wilfordii. This paper systematically reviewed current research me-thods for analyzing the biosynthetic functional genes of active ingredients in TCM, elaborated the mining of gene elements based on multiomics technology and the verification of gene functions in plants in vitro and in vivo with candidate genes as objects. Additionally, the paper summarized new technologies and methods that have emerged in recent years, such as high-throughput screening, molecular probes, genome-wide association studies, cell-free systems, and computer simulation screening to provide a comprehensive reference for the analysis of the biosynthetic pathways of active ingredients in TCM.


Assuntos
Medicamentos de Ervas Chinesas , Medicina Tradicional Chinesa , Inteligência Artificial , Vias Biossintéticas , Simulação por Computador , Estudo de Associação Genômica Ampla
2.
Mol Brain ; 10(1): 38, 2017 08 11.
Artigo em Inglês | MEDLINE | ID: mdl-28800762

RESUMO

The G protein-coupled receptor 55 (GPR55) is a novel cannabinoid receptor, whose exact role in anxiety remains unknown. The present study was conducted to explore the possible mechanisms by which GPR55 regulates anxiety and to evaluate the effectiveness of O-1602 in the treatment of anxiety-like symptoms. Mice were exposed to two types of acute stressors: restraint and forced swimming. Anxiety behavior was evaluated using the elevated plus maze and the open field test. We found that O-1602 alleviated anxiety-like behavior in acutely stressed mice. We used lentiviral shRNA to selective ly knockdown GPR55 in the medial orbital cortex and found that knockdown of GPR55 abolished the anxiolytic effect of O-1602. We also used Y-27632, a specific inhibitor of ROCK, and U73122, an inhibitor of PLC, and found that both inhibitors attenuated the effectiveness of O-1602. Western blot analysis revealed that O-1602 downregulated the expression of GluA1 and GluN2A in mice. Taken together, these results suggest that GPR55 plays an important role in anxiety and O-1602 may have therapeutic potential in treating anxiety-like symptoms.


Assuntos
Ansiedade/metabolismo , Ansiedade/psicologia , Córtex Pré-Frontal/metabolismo , Receptores de Canabinoides/metabolismo , Estresse Psicológico/metabolismo , Doença Aguda , Amidas/administração & dosagem , Amidas/farmacologia , Amidas/uso terapêutico , Animais , Ansiolíticos/administração & dosagem , Ansiolíticos/farmacologia , Ansiolíticos/uso terapêutico , Ansiedade/tratamento farmacológico , Canabidiol/análogos & derivados , Doença Crônica , Cicloexanos/farmacologia , Cicloexanos/uso terapêutico , Estrenos/farmacologia , Técnicas de Silenciamento de Genes , Injeções Intraperitoneais , Masculino , Camundongos Endogâmicos C57BL , Piridinas/administração & dosagem , Piridinas/farmacologia , Piridinas/uso terapêutico , Pirrolidinonas/farmacologia , Resorcinóis/farmacologia , Resorcinóis/uso terapêutico , Restrição Física , Transdução de Sinais , Estresse Psicológico/tratamento farmacológico , Natação
3.
Int Immunopharmacol ; 41: 66-73, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27816787

RESUMO

The analgesic effects of gastrodin (GAS), an active component derived from the Chinese herb Tian ma (Gastrodia elata Blume), on chronic inflammatory pain of mice and the involved molecular mechanisms were investigated. GAS significantly attenuated mice chronic inflammatory pain induced by hindpaw injection of complete Freund's adjuvant (CFA) and the accompanying anxiety-like behaviors. GAS administration reduced CFA-induced up-regulation of GluR1-containing α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, GluN2A- and GluN2B-containing N-methyl-d-aspartate (NMDA) receptors, and Ca2+/calmodulin-dependent protein kinase II-alpha (CaMKII-α) in the anterior cingulate cortex (ACC). The GluN2A and GluN2B subunits of NMDA receptors, the GluR1 type of AMPA receptor, and CaMKII-α are key molecules responsible for neuroplasticity involved in chronic pain and the accompanying anxiety. Moreover, GAS administration reduced the activation of astrocyte and microglia and the induction of TNF-α and IL-6 in the ACC of the CFA-injected mice. Therefore, GAS administration relieved chronic pain, exerted anxiolytic effects by regulating neuroplasticity molecules, and attenuated the inflammatory response by reducing the induction of TNF-α and IL-6 in the ACC of the CFA-injected mice.


Assuntos
Analgésicos/uso terapêutico , Ansiolíticos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Álcoois Benzílicos/uso terapêutico , Glucosídeos/uso terapêutico , Hiperalgesia/tratamento farmacológico , Dor/tratamento farmacológico , Analgésicos/farmacologia , Animais , Ansiolíticos/farmacologia , Anti-Inflamatórios/farmacologia , Ansiedade/tratamento farmacológico , Ansiedade/metabolismo , Astrócitos/efeitos dos fármacos , Astrócitos/metabolismo , Álcoois Benzílicos/farmacologia , Proteínas de Ligação ao Cálcio/metabolismo , Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina/metabolismo , Adjuvante de Freund , Proteína Glial Fibrilar Ácida/metabolismo , Glucosídeos/farmacologia , Giro do Cíngulo/efeitos dos fármacos , Giro do Cíngulo/metabolismo , Temperatura Alta , Hiperalgesia/induzido quimicamente , Hiperalgesia/metabolismo , Interleucina-6/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Proteínas dos Microfilamentos/metabolismo , Microglia/efeitos dos fármacos , Microglia/metabolismo , Dor/induzido quimicamente , Dor/metabolismo , Receptores de AMPA/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , Tato , Fator de Necrose Tumoral alfa/metabolismo
4.
Biotechnol Lett ; 26(11): 885-90, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15269535

RESUMO

To produce an industrial strain of Saccharomyces cerevisiae that metabolizes xylose, we constructed a rDNA integration vector and YIp integration vector, containing the xylose-utilizing genes, XYL1 and XYL2, which encode xylose reductase (XR) and xylitol dehydrogenase (XDH) from Pichia stipitis, and XKS1, which encodes xylulokinase (XK) from S. cerevisiae, with the G418 resistance gene KanMX as a dominant selectable marker. The rDNA results in integration of multiple copies of the target genes. The industrial stain of S. cerevisiae NAN-27 was transformed with the two integration vectors to produce two recombinant strains, S. cerevisiae NAN-127 and NAN-123. Upon transformation, multiple copies of the xylose-utilizing genes were integrated into the genome rDNA locus of S. cerevisiae. Strain NAN-127 consumed twice as much xylose and produced 39% more ethanol than the parent strain, while NAN-123 consumed 10% more xylose and produced 10% more ethanol than the parent strain over 94 h.


Assuntos
Etanol/metabolismo , Melhoramento Genético/métodos , Microbiologia Industrial/métodos , Engenharia de Proteínas/métodos , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Xilose/metabolismo , Proliferação de Células , Proteínas Recombinantes/metabolismo , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo , Transdução de Sinais/fisiologia , Especificidade da Espécie
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...